Plandai Biotech Stock Shares Outstanding
Plandai Biotech fundamentals help investors to digest information that contributes to Plandai Biotech's financial success or failures. It also enables traders to predict the movement of Plandai Pink Sheet. The fundamental analysis module provides a way to measure Plandai Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Plandai Biotech pink sheet.
Plandai |
Plandai Biotech Company Shares Outstanding Analysis
Plandai Biotech's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Plandai Biotech Shares Outstanding | 263.19 M |
Most of Plandai Biotech's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Plandai Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Plandai Biotech has 263.19 M of shares currently outstending. This is 85.66% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 53.97% higher than that of the company.
Plandai Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Plandai Biotech's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Plandai Biotech could also be used in its relative valuation, which is a method of valuing Plandai Biotech by comparing valuation metrics of similar companies.Plandai Biotech is currently under evaluation in shares outstanding category among its peers.
Plandai Fundamentals
| Return On Asset | -0.21 | |||
| Operating Margin | (12.22) % | |||
| Current Valuation | 236.87 K | |||
| Shares Outstanding | 263.19 M | |||
| Price To Earning | (0.32) X | |||
| Price To Sales | 1.04 X | |||
| Revenue | 411.99 K | |||
| Gross Profit | (768.91 K) | |||
| EBITDA | (2.1 M) | |||
| Net Income | (4.01 M) | |||
| Cash And Equivalents | 7.96 K | |||
| Total Debt | 50.53 K | |||
| Debt To Equity | 0.95 % | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (0.05) X | |||
| Cash Flow From Operations | (1.1 M) | |||
| Earnings Per Share | (0.03) X | |||
| Number Of Employees | 250 | |||
| Beta | -1.3 | |||
| Market Capitalization | 276.35 K | |||
| Total Asset | 6.82 M | |||
| Retained Earnings | (39.32 M) | |||
| Working Capital | (15.26 M) | |||
| Current Asset | 176 K | |||
| Current Liabilities | 15.44 M | |||
| Z Score | -6.4 | |||
| Net Asset | 6.82 M |
About Plandai Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Plandai Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Plandai Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Plandai Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Plandai Pink Sheet
Plandai Biotech financial ratios help investors to determine whether Plandai Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Plandai with respect to the benefits of owning Plandai Biotech security.